Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine versus lidocaine for inferior alveolar nerve block in symptomatic irreversible pulpitis
IRCT20211230053569N1Phase 2Completed
- Sponsor
- Riphah International University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irreversible pulpitis comparing Articaine arm with Lidocaine control arm (2 arms). Primary endpoint: Pain relief after anesthesia. Started Aug 2022; status: completed.
02
Drugs
articainelidocaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20211230053569N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211230053569N1.